arrow
Back
H

Hubert G. M. Leufkens

utrecht institute of pharmaceutical science

72H-index
509Paper Count
2.0WCitation Count
Published Papers 238
Publication Date
European Science for Health Research Needs and Priorities
err2026-05-30
err0
errOAAI
errMareike Lutz; Tessa Moleman; Hubert G.M. Leufkens
errShare
errSave
Medicines not recommended for inclusion in the who essential medicines list: a retrospective observational study
err2025-03-17
err0
errOAAI
errCosta, Enrico; Del Grosso, Vittorio; Cappello, Bernadette; Genazzani, Armando A.; Huttner, Benedikt; Leufkens, Hubert G. M.; Magrini, Nicola; Nonino, Francesco; Wirtz, Veronika J.; van den Ham, Hendrika A.; Moja, Lorenzo
errShare
errSave
Differential times of submission and approval of CFTR modulators for the treatment of Cystic Fibrosis in the United States and the European Union
err2025-01-01
err2
errOAAI
errCosta, Enrico; Girotti, Silvia; Mathieu, Clement; Castellani, Carlo; Ross, Joseph S.; Taylor-Cousar, Jennifer L.; Leufkens, Hubert G. M.
errShare
errSave
Globalization in clinical drug development for sickle cell disease
err2024-11-12
err0
errOAAI
errCosta, Enrico; Ware, Russell E.; Tshilolo, Leon; Makani, Julie; Leufkens, Hubert G. M.; Luzzatto, Lucio
errShare
errSave
Feasibility of disease terminology systems for mapping orphan conditions and therapeutic indications of designated orphan medicines in the European Union
err2024-11-01
err0
errOAAI
errJadoenathmisier, Keerti; Stoyanova-Beninska, Violeta; Soons, Inge M.; Leufkens, Hubert G. M.; Bloem, Lourens; Pasmooij, Anna M. G.
errShare
errSave
Identifying Medicine Shortages With the Twitter Social Network: Retrospective Observational Study
err2024-08-06
err0
errOAAI
errPostma, Doerine J.; Heijkoop, Magali L. A.; De Smet, Peter A. G. M.; Notenboom, Kim; Leufkens, Hubert G. M.; Mantel-Teeuwisse, Aukje K.
errShare
errSave
Successes and pitfalls in orphan drug development for sickle cell disease
err2024-05-20
err1
errOAAI
errCosta, Enrico; Isgro, Antonella; de Montalembert, Mariane; Leufkens, Hubert G. M.; Ware, Russell E.; De Franceschi, Lucia
errShare
errSave
The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report
err2024-04-28
err0
errOAAI
errPasmooij, Anna M. G.; Mol, Peter G. M.; Bot, Jacob Cornelis; Leufkens, Hubert G. M.
errShare
errSave
Medicine shortages: impact behind numbers
err2024-03-11
err12
errOAAI
errPostma, Doerine J.; Notenboom, Kim; De Smet, Peter A. G. M.; Leufkens, Hubert G. M.; Mantel-Teeuwisse, Aukje K.
errShare
errSave
Trends in orphan medicinal products approvals in the European Union between 2010-2022
err2024-02-27
err8
errOAAI
errBouwman, Luisa; Sepodes, Bruno; Leufkens, Hubert; Torre, Carla
errShare
errSave
Uptake of orphan drugs in the WHO essential medicines lists
err2024-01-01
err7
errOAAI
errCosta, Enrico; Moja, Lorenzo; Wirtz, Veronika J.; van den Ham, Hendrika A.; Huttner, Benedikt; Magrini, Nicola; Leufkens, Hubert G. M.
errShare
errSave
Post-approval quality-related regulatory actions for biopharmaceuticals approved in the European Union and the United States between 1995 and 2019
err2023-10-01
err1
errOAAI
errAlsamil, Ali M.; Gardarsdottir, Helga; Leufkens, Hubert G.; Egberts, Toine C.; Giezen, Thijs J.
errShare
errSave
Traits, trends and hits of orphan drug designations in cystic fibrosis
err2023-09-01
err2
errOAAI
errCosta, Enrico; Girotti, Silvia; van den Ham, Hendrika A.; Cipolli, Marco; van der Ent, Cornelis K.; Taylor-Cousar, Jennifer L.; Leufkens, Hubert G. M.
errShare
errSave
Pharmaceutical Scientists' Perspectives on Capacity Building in Pharmaceutical Sciences
err2023-07-01
err0
errOAAI
errKusynova, Z.; van den Ham, H. A.; Leufkens, H. G. M.; Mantel-Teeuwisse, A. K.
errShare
errSave
Longitudinal study of Good Pharmacy Practice roles covered at the annual world pharmacy congresses 2003-2019
err2022-11-28
err3
errOAAI
errKusynova, Zuzana; van den Ham, Hendrika A.; Leufkens, Hubert G. M.; Mantel-Teeuwisse, Aukje K.
errShare
errSave
Emergent treatments for β-thalassemia and orphan drug legislations
err2022-11-01
err5
errOAAI
errEnrico, Costa; Maria, Domenica Cappellini; Stefano, Rivella; Adriana, Chilin; Eva, Alessi; Massimo, Riccaboni; Hubert, G. M. Leufkens; Luzzatto, Lucio
errShare
errSave
errShare
errSave
Four scenarios for the future of medicines and social policy in 2030
err2022-08-01
err7
errOAAI
errLeufkens, Hubert G.; Kusynova, Zuzana; Aitken, Murray; Hoekman, Jarno; Stolk, Pieter; Klein, Kevin; Mantel-Teeuwisse, Aukje K.
errShare
errSave